CD80
免疫系统
结直肠癌
CD86
癌症
癌症疫苗
免疫疗法
体内
医学
免疫学
佐剂
微生物学
生物
T细胞
体外
CD40
细胞毒性T细胞
生物技术
内科学
生物化学
作者
Milda Naciūtė,Tamara Kiwitt,Roslyn A. Kemp,Sarah Hook
出处
期刊:Vaccine
[Elsevier BV]
日期:2021-09-01
卷期号:39 (39): 5589-5599
被引量:11
标识
DOI:10.1016/j.vaccine.2021.08.028
摘要
Bacteria biohybrid-based vaccine delivery systems, which integrate a vaccine carrier with live non-pathogenic bacteria, are hypothesized to have improved immunostimulating potential. The aim of this study was to develop oral bacteria biohybrid-based vaccines to treat a mouse model of colorectal cancer. E. coli were combined with tumor antigen- and adjuvant-containing emulsions or liposomes. Emulsion and liposome biohybrid vaccines demonstrated in vitro and in vivo therapeutic potential. Bacteria biohybrid vaccines significantly increased the expression of CD40+, CD80+ and CD86+ on murine bone marrow-derived dendritic cells. Mice vaccinated with emulsion biohybrid vaccines had an increased CD8+ T cell infiltration into tumors and developed three-fold smaller tumors compared to the mice that received emulsion vaccine without E. coli.
科研通智能强力驱动
Strongly Powered by AbleSci AI